Lonza Appoints Wolfgang Wienand as New Chief Executive Officer
|
Lonza Group AG / Key word(s): Personnel Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland, 2 April 2024 – The Board of Directors of Lonza today announced that Wolfgang Wienand has been appointed Chief Executive Officer (CEO), and will join the company during the summer of 2024. Wolfgang is currently CEO of the Swiss contract development and manufacturing organization (CDMO) Siegfried Holding AG, a role he has held since 2019. Prior to this, Wolfgang first served as Chief Scientific Officer and then as Chief Strategy Officer in Siegfried’s executive leadership team. Before joining Siegfried in 2010, Wolfgang held a series of increasingly senior positions at the German specialty chemicals company Evonik Industries. Wolfgang will succeed Albert M. Baehny, who took on the additional responsibility of CEO on an ad interim basis in October 2023 while the search for a permanent CEO took place. Albert will remain at Lonza for a transition period during the summer, before retiring from the company. Albert M. Baehny, Chairman of the Board of Directors and CEO ad interim, Lonza, commented: “The Board is delighted to have appointed a seasoned CEO with a strong and established track record of success in the CDMO industry. Wolfgang brings a wealth of knowledge and experience to Lonza, complemented by his deep scientific and strategic expertise. With his proven leadership capabilities, Wolfgang is ideally placed to act as an ambassador for our business and lead our colleague community as Lonza enters the next chapter of its growth journey.” Christoph Mäder, Lead Independent Director and Vice-Chairman, Lonza, added: “Wolfgang is a high-caliber leader with outstanding CDMO experience. He will be a great asset to our business. As Wolfgang takes the role of CEO, Albert Baehny will step down from his ad interim CEO position. I would like to take this chance to thank Albert for his extraordinary dedication and leadership in recent months. As Albert also plans to step down from the Board of Directors in May, I would also like to take this chance to thank him for the critical role he has played in the growth and transformation of our business during his time as Chairman.” Wolfgang Wienand, incoming Chief Executive Officer, Lonza, commented: “I am very much looking forward to joining Lonza and leading the company into a strong future. Lonza is world class, as is the scientific, technological and market expertise of its people. It is this unique position that enables the Lonza team to push the boundaries of pharmaceutical development and manufacturing, and serve as a partner of choice for the global biopharma industry in its quest to turn breakthrough innovations into viable therapies. Together, we will enable a healthier world for patients in need.” Note to editors: About Lonza Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients. Our company generated sales of CHF 6.7 billion with a CORE EBITDA of CHF 2.0 billion in Full-Year 2023. Find out more at www.lonza.com Lonza Contact Details Media Inquiries: Investor Inquiries: End of Inside Information |
| Language: | English |
| Company: | Lonza Group AG |
| Münchensteinerstrasse 38 | |
| 4052 Basel | |
| Switzerland | |
| Phone: | +4161 316 81 11 |
| Internet: | www.lonza.com |
| ISIN: | CH0013841017 |
| Valor: | 1384101 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1870895 |
| End of Announcement | EQS News Service |
|
|
1870895 02-Apr-2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.